Cargando…

Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors

Detalles Bibliográficos
Autores principales:	Gasparyan, Armen Yuri, Kitas, George D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450206/ https://www.ncbi.nlm.nih.gov/pubmed/36128214 http://dx.doi.org/10.31138/mjr.33.2.173

Ejemplares similares

PubMed Central archiving: a major milestone for a scholarly journal
por: Gasparyan, Armen Yuri, et al.
Publicado: (2020)

Steps towards quality of open access publishing
por: Gasparyan, Armen Yuri, et al.
Publicado: (2018)

Editorial Strategy to Get a Scholarly Journal Indexed by Scopus
por: Gasparyan, Armen Yuri, et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management
por: Mehta, Pankti, et al.
Publicado: (2022)

Monitoring Information Flow on Coronavirus Disease 2019 (COVID-19)
por: Gasparyan, Armen Yuri, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Best peer reviewers and the quality of peer review in biomedical journals
por: Gasparyan, Armen Yuri, et al.
Publicado: (2012)

Choosing the Target Journal: Do Authors Need a Comprehensive Approach?
por: Gasparyan, Armen Yuri
Publicado: (2013)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses
por: Mehta, Pankti, et al.
Publicado: (2022)

Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
por: Marwah, Vikas, et al.
Publicado: (2021)

Biomedical journal editing: elements of success
por: Gasparyan, Armen Yuri, et al.
Publicado: (2011)

Multidisciplinary Bibliographic Databases
por: Gasparyan, Armen Yuri, et al.
Publicado: (2013)

Open access: changing global science publishing
por: Gasparyan, Armen Yuri, et al.
Publicado: (2013)

Global Health Strategies in the Face of the COVID-19 Pandemic and Other Unprecedented Threats
por: Gasparyan, Armen Yuri, et al.
Publicado: (2022)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19
por: Cothran, Thomas P., et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Bibliographic Databases: Some Critical Points
por: Gasparyan, Armen Yuri
Publicado: (2013)

Authorship and Contributorship in Scholarly Journals
por: Gasparyan, Armen Yuri
Publicado: (2013)

Researchers and Editors at the Heart of Science Communication
por: Gasparyan, Armen Yuri
Publicado: (2014)

Peer Review in Scholarly Biomedical Journals: a Few Things that Make a Big Difference
por: Gasparyan, Armen Yuri
Publicado: (2013)

Selecting Your Editorial Board: Maintaining Standards
por: Gasparyan, Armen Yuri
Publicado: (2013)

Upgrading instructions for authors of scholarly journals
por: Gasparyan, Armen Yuri, et al.
Publicado: (2014)

Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors
por: Gasparyan, Armen Yuri, et al.
Publicado: (2013)

Self-correction in biomedical publications and the scientific impact
por: Gasparyan, Armen Yuri, et al.
Publicado: (2014)

Publishing Ethics and Predatory Practices: A Dilemma for All Stakeholders of Science Communication
por: Gasparyan, Armen Yuri, et al.
Publicado: (2015)

Educating science editors: is there a comprehensive strategy?
por: Gasparyan, Armen Yuri, et al.
Publicado: (2014)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
por: La Rosée, F., et al.
Publicado: (2020)

Systematic and Open Identification of Researchers and Authors: Focus on Open Researcher and Contributor ID
por: Gasparyan, Armen Yuri, et al.
Publicado: (2014)

Rewarding Peer Reviewers: Maintaining the Integrity of Science Communication
por: Gasparyan, Armen Yuri, et al.
Publicado: (2015)

The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases
por: Gasparyan, Armen Yuri, et al.
Publicado: (2019)

Scientific Hypotheses: Writing, Promoting, and Predicting Implications
por: Gasparyan, Armen Yuri, et al.
Publicado: (2019)

Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
por: Auanassova, Akerke, et al.
Publicado: (2022)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b87srgqidlme2qev4mcqlvhhl3